The Management of Metastatic Bone Cancer
Churchill Livingstone (Publisher)
Will be published approx. on 12. December 2050
Book
Hardback
224 pages
978-0-443-07273-4 (ISBN)
Description
The Management of Metastatic Bone Cancer covers the most recent clinical advances in this area in a concise, practical, and very visually attractive manner. It is a concise and accessible text, enhanced with specially commissioned state-of-the-art computer graphics, and full color illustrations. It presents a comprehensive and very up-to-date account of all the important issues affecting the investigation, diagnosis and management of this disease, with special emphasis on surgical, radiotherapeutic and drug treatment. There are additional chapters covering hypercalcemia and osteoporosis in metastatic bone cancer. Written by a world-class author team comprising medical oncologists, radiation oncologists, orthopedic surgeons and nurses, The Management of Metastatic Bone Cancer reflects the team approach taken to treat this life-threatening disease.Feature: Clear and accessible style. Benefit: Easy to read and understand.
Feature: Full colour illustration. Benefit: Difficult concepts clearly explained. Clinical photographs reproduced as they appear in real life.
Feature: Very up-to-date. Benefit: Provides timely advice
Feature: Covers current hot topics such as the very latest on bisphosphonate drugs. Benefit: Provides clear advice on new issues which concern the reader
Feature: International, multidisciplinary author team. Benefit: Provides depth and breadth of knowledge.
Feature: Key points boxes at opening of chapters. Benefit: Summarises current developments at a glance.
Feature: Full colour illustration. Benefit: Difficult concepts clearly explained. Clinical photographs reproduced as they appear in real life.
Feature: Very up-to-date. Benefit: Provides timely advice
Feature: Covers current hot topics such as the very latest on bisphosphonate drugs. Benefit: Provides clear advice on new issues which concern the reader
Feature: International, multidisciplinary author team. Benefit: Provides depth and breadth of knowledge.
Feature: Key points boxes at opening of chapters. Benefit: Summarises current developments at a glance.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
College/higher education
Professional and scholarly
Primary: Oncologists, radiotherapists and orthopaedic surgeons
Secondary: Family care practitioners, primary care physicians
Dimensions
Height: 246 mm
Width: 189 mm
Weight
1000 gr
ISBN-13
978-0-443-07273-4 (9780443072734)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Author
Director of the Multiple Myeloma and Bone Metastasis Research Programs, Cedars-Sinai Medical Center, Professor of Medicine, Hematology-Oncology, University of California Los Angeles; Chief of Cancer Research, Associate Director of Research, West Los Angeles VA Medical Center, Los Angeles, CA, USA
Reader and Honorary Consultant, Department of Clinical Oncology, Central Sheffield University Hospital, Weston Park Hospital, Sheffield, UK
Dept. of Clinical Oncology
Dept. of Clinical Oncology
Professor, Department of Medicine, Chief, Division of Endocrinology, University of Texas Health Science Center at San Antonio
Professor, Department of Medicine
Professor, Department of Medicine
Content
Normal bone Mundy
Biology of metastatic bone disease: Myeloma Berenson and Mundy
Biology of metastatic bone disease: Solid tumors, breast and lung Berenson and Mundy
Biology of metastatic bone disease: Osteoblastic tumors, prostate Berenson and Mundy
Epidemiology and the extent of the problem
Evaluating metastatic bone disease (to cover radiology and bone markers)
Clinical manifestations of metastatic bone disease (to cover myeloma, prostate and breast)
Treatment: surgery
Treatment: radiotherapy
Treatment: bisphosphonates (covering myeloma, breast, prostate and other tumors) Berenson and Coleman
New drugs Berenson
Hypercalcemia Mundy
Osteoporosis from cancer therapy Mundy
Nursing issues Swift
Future developments in the management of metastatic bone cancer
Biology of metastatic bone disease: Myeloma Berenson and Mundy
Biology of metastatic bone disease: Solid tumors, breast and lung Berenson and Mundy
Biology of metastatic bone disease: Osteoblastic tumors, prostate Berenson and Mundy
Epidemiology and the extent of the problem
Evaluating metastatic bone disease (to cover radiology and bone markers)
Clinical manifestations of metastatic bone disease (to cover myeloma, prostate and breast)
Treatment: surgery
Treatment: radiotherapy
Treatment: bisphosphonates (covering myeloma, breast, prostate and other tumors) Berenson and Coleman
New drugs Berenson
Hypercalcemia Mundy
Osteoporosis from cancer therapy Mundy
Nursing issues Swift
Future developments in the management of metastatic bone cancer